Found: 44
Select item for more details and to access through your institution.
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides.
- Published in:
- Nature Medicine, 2002, v. 8, n. 5, p. 527, doi. 10.1038/nm0502-527
- By:
- Publication type:
- Article
CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes.
- Published in:
- Stem Cells Translational Medicine, 2020, v. 9, n. 10, p. 1203, doi. 10.1002/sctm.20-0019
- By:
- Publication type:
- Article
Oncolytic virotherapy.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 658, doi. 10.1038/nbt.2287
- By:
- Publication type:
- Article
Rescue and propagation of fully retargeted oncolytic measles viruses.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 2, p. 209, doi. 10.1038/nbt1060
- By:
- Publication type:
- Article
Antibody-targeted cell fusion.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073759
- By:
- Publication type:
- Article
Long-Term Infection and Vertical Transmission of a Gammaretrovirus in a Foreign Host Species.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029682
- By:
- Publication type:
- Article
Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for <sup>153</sup>Samarium-EDTMP doping.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Amalgamating Oncolytic Viruses to Enhance Their Safety, Consolidate Their Killing Mechanisms, and Accelerate Their Spread.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 10, p. 1930, doi. 10.1038/mt.2013.164
- By:
- Publication type:
- Article
DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 4, p. 849, doi. 10.1038/mt.2013.16
- By:
- Publication type:
- Article
Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 6, p. 1139, doi. 10.1038/mt.2012.4
- By:
- Publication type:
- Article
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1279387
- By:
- Publication type:
- Article
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 7, p. 593, doi. 10.1038/sj.cgt.7700823
- By:
- Publication type:
- Article
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00127
- By:
- Publication type:
- Article
Safety, pharmacokinetics, metabolism and radiation dosimetry of F-tetrafluoroborate (F-TFB) in healthy human subjects.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0337-5
- By:
- Publication type:
- Article
Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 349, p. 1, doi. 10.1126/scitranslmed.aaf3838
- By:
- Publication type:
- Article
TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S416, doi. 10.1016/S2152-2650(21)01935-2
- By:
- Publication type:
- Article
Poster: TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01560-3
- By:
- Publication type:
- Article
Synthesis of <sup>18</sup>F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 9, p. 1454, doi. 10.2967/jnumed.115.170894
- By:
- Publication type:
- Article
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.
- Published in:
- Prostate, 2009, v. 69, n. 10, p. 1128, doi. 10.1002/pros.20962
- By:
- Publication type:
- Article
Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-20
- By:
- Publication type:
- Article
Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome.
- Published in:
- Journal of Gene Medicine, 2009, v. 11, n. 3, p. 197, doi. 10.1002/jgm.1289
- By:
- Publication type:
- Article
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
- Published in:
- Journal of Gene Medicine, 2004, v. 6, n. 11, p. 1216, doi. 10.1002/jgm.616
- By:
- Publication type:
- Article
Concentration of viral vectors by co-precipitation with calcium phosphate.
- Published in:
- Journal of Gene Medicine, 2001, v. 3, n. 2, p. 188, doi. 10.1002/1521-2254(2000)9999:9999<::AID-JGM159>3.0.CO;2-9
- By:
- Publication type:
- Article
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 7, p. 401, doi. 10.1002/ajh.21444
- By:
- Publication type:
- Article
Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 6, p. 1155, doi. 10.1038/mt.2010.43
- By:
- Publication type:
- Article
Intravascularly Administered RGD-Displaying Measles Viruses Bind to and Infect Neovessel Endothelial Cells In Vivo.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 6, p. 1012, doi. 10.1038/mt.2009.39
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor (EGFR)–Retargeted Measles Virus Strains Effectively Target EGFR- or EGFRvIII Expressing Gliomas.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 4, p. 677, doi. 10.1038/sj.mt.6300105
- By:
- Publication type:
- Article
Engineering Oncolytic Measles Virus to Circumvent the Intracellular Innate Immune Response.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 3, p. 588, doi. 10.1038/sj.mt.6300076
- By:
- Publication type:
- Article
957. Effect of Ligand Binding Affinity and Receptor Density in Relation to Biology of Retargeted Viruses.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S369, doi. 10.1016/j.ymthe.2006.08.1049
- By:
- Publication type:
- Article
297. Safety of Repeat Intracerebral Administration of MV-CEA in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S113, doi. 10.1016/j.ymthe.2006.08.352
- By:
- Publication type:
- Article
482. T Cells as Carriers for Systemic Measles Virotherapy of Multiple Myeloma.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S187, doi. 10.1016/j.ymthe.2006.08.551
- By:
- Publication type:
- Article
729. Phase I Trial of Intraperitoneal (IP) Administration of a Measles Virus (MV) Strain Expressing the Human Carcinoembryonic Antigen (CEA) in Ovarian Cancer Patients.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S281, doi. 10.1016/j.ymthe.2006.08.809
- By:
- Publication type:
- Article
775. Folate Receptor Targeted Virotherapy of Ovarian Cancer Using a Tropism Modified Measles Virus.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S300, doi. 10.1016/j.ymthe.2006.08.861
- By:
- Publication type:
- Article
1010. A β-hCG Expressing Trackable and Tumor Targeted Conditionally Replicating Adenovirus for Treatment of Prostate Cancer
- Published in:
- 2005
- By:
- Publication type:
- Abstract
721. Measles Virus for Cancer Gene Therapy of Primary Liver Tumors
- Published in:
- 2005
- By:
- Publication type:
- Abstract
303. Validating CD46 as a Possible Mechanism Contributing to MV-Edm Oncolytic Specificity
- Published in:
- 2005
- By:
- Publication type:
- Abstract
297. Radiovirotherapy in Ovarian Cancer Using Recombinant Measles Expressing Sodium Iodide Symporter
- Published in:
- 2005
- By:
- Publication type:
- Abstract
73. Fully Retargeted Oncolytic Measles Viruses for Cancer Therapy
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep02375
- By:
- Publication type:
- Article
Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck.
- Published in:
- Head & Neck, 2014, v. 36, n. 11, p. 1619, doi. 10.1002/hed.23502
- By:
- Publication type:
- Article
New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imaging.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32442-x
- By:
- Publication type:
- Article
Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
- Published in:
- BioDrugs, 2019, v. 33, n. 5, p. 485, doi. 10.1007/s40259-019-00367-0
- By:
- Publication type:
- Article